Research graph
References from Adjunctive traditional Chinese medicine for ischemic stroke: a systematic review with structured narrative synthesis and GRADE assessment of randomized controlled trials. Local targets link to admitted publications; unresolved targets remain external evidence.
Global burden of stroke: insights and trends from GBD 2021
2025 · External reference
Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association
10.1161/str.0000000000000211 · 2019 · External reference
Study on delay factors and time to hospital arrival after acute stroke in patients at Shahid Rajaei hospital, Tonekabon (2022-2023)
10.1186/s12883-025-04361-8 · 2025 · External reference
Stroke rehabilitation: from diagnosis to therapy
10.3389/fneur.2024.1402729 · 2024 · External reference
Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review
10.3389/fphar.2025.1561688 · 2025 · External reference
Therapeutic effect of Chinese herbal medicines for post stroke recovery: a traditional and network meta-analysis
10.1097/md.0000000000008830 · 2017 · External reference
Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies
10.3390/ijms23010014 · 2022 · External reference
Tongxinluo and functional outcomes among patients with acute ischemic stroke: a randomized clinical trial
10.1001/jamanetworkopen.2024.33463 · 2024 · External reference
Efficacy and safety of Panax notoginseng saponins in the treatment of adults with ischemic stroke in china: a randomized clinical trial
10.1001/jamanetworkopen.2023.17574 · 2023 · External reference
Effect of age on the efficacy and safety of Panax notoginseng saponins in acute ischemic stroke: a prespecified secondary analysis of the PANDA study
10.1186/s13020-025-01101-5 · 2025 · External reference
Naoxintong capsule for secondary prevention of ischemic stroke: a multicenter, randomized, and placebo-controlled trial
10.1007/s11655-022-3586-8 · 2022 · External reference
The add-on effect of dengzhan shengmai capsules on secondary prevention of ischemic stroke: a multicentre, randomised, placebo-controlled clinical trial
10.1016/j.ctim.2019.08.015 · 2019 · External reference
Effect of Qizhitongluo capsule on lower limb rehabilitation after stroke: a randomized clinical trial
10.1016/j.phrs.2021.105464 · 2021 · External reference
Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study
10.1161/strokeaha.113.002055 · 2013 · External reference
A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional Chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS)
10.1159/000247001 · 2009 · External reference
Methodological, reporting, and evidence quality of systematic reviews of traditional Chinese medicine for ischemic stroke
10.3389/fphar.2023.1047650 · 2023 · External reference
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
10.1136/bmj.l6890 · 2020 · External reference
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
10.1136/bmj.39489.470347.ad · 2008 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021 · External reference
PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews
10.1186/s13643-020-01542-z · 2021 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
Randomized, double-blind, parallel-controlled clinical trial on correspondence of prescriptions and traditional Chinese medicine syndrome of ischemic stroke
10.1016/s0254-6272(13)60034-5 · 2012 · External reference
Safety and efficacy of Angong Niuhuang pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): a randomized double-blind placebo-controlled pilot clinical trial
10.1097/cm9.0000000000003133 · 2025 · External reference
The positive effects of Xueshuan Xinmai tablets on brain functional connectivity in acute ischemic stroke: a placebo controlled randomized trial
10.1038/s41598-017-15456-9 · 2017 · External reference
Effectiveness and safety of Angong Niuhuang pill in treatment of acute stroke: a systematic review and meta-analysis
10.19852/j.cnki.jtcm.20230526.002 · 2023 · External reference
Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: a meta-analysis of randomized controlled trials
10.1016/j.jep.2019.03.043 · 2019 · External reference
